Similar articles for PMID: 21304399

Year	Number of Results
1991	1
1993	1
1995	1
1996	2
1997	1
2002	1
2003	4
2004	2
2005	4
2006	6
2007	13
2008	9
2009	13
2010	13
2011	15
2012	8
2013	15
2014	12
2015	5
2016	9
2017	7
2018	9
2019	12
2020	9
2021	3
2022	6
2023	6
2024	0

1

Adoptive immunotherapy for advanced non-small cell lung cancer using zoledronate-expanded γδTcells: a phase I clinical study.

Sakamoto M, Nakajima J, Murakawa T, Fukami T, Yoshida Y, Murayama T, Takamoto S, Matsushita H, Kakimi K. Sakamoto M, et al. J Immunother. 2011 Mar;34(2):202-11. doi: 10.1097/CJI.0b013e318207ecfb. J Immunother. 2011. PMID: 21304399 Clinical Trial.

2

Zoledronate facilitates large-scale ex vivo expansion of functional gammadelta T cells from cancer patients for use in adoptive immunotherapy.

Kondo M, Sakuta K, Noguchi A, Ariyoshi N, Sato K, Sato S, Sato K, Hosoi A, Nakajima J, Yoshida Y, Shiraishi K, Nakagawa K, Kakimi K. Kondo M, et al. Cytotherapy. 2008;10(8):842-56. doi: 10.1080/14653240802419328. Cytotherapy. 2008. PMID: 19016372

3

Phase I/II study of adoptive transfer of γδ T cells in combination with zoledronic acid and IL-2 to patients with advanced renal cell carcinoma.

Kobayashi H, Tanaka Y, Yagi J, Minato N, Tanabe K. Kobayashi H, et al. Cancer Immunol Immunother. 2011 Aug;60(8):1075-84. doi: 10.1007/s00262-011-1021-7. Epub 2011 Apr 26. Cancer Immunol Immunother. 2011. PMID: 21519826 Clinical Trial.

4

Type I IFN-mediated enhancement of anti-leukemic cytotoxicity of gammadelta T cells expanded from peripheral blood cells by stimulation with zoledronate.

Watanabe N, Narita M, Yokoyama A, Sekiguchi A, Saito A, Tochiki N, Furukawa T, Toba K, Aizawa Y, Takahashi M. Watanabe N, et al. Cytotherapy. 2006;8(2):118-29. doi: 10.1080/14653240600620200. Cytotherapy. 2006. PMID: 16698685

5

A phase I study of adoptive immunotherapy for recurrent non-small-cell lung cancer patients with autologous gammadelta T cells.

Nakajima J, Murakawa T, Fukami T, Goto S, Kaneko T, Yoshida Y, Takamoto S, Kakimi K. Nakajima J, et al. Eur J Cardiothorac Surg. 2010 May;37(5):1191-7. doi: 10.1016/j.ejcts.2009.11.051. Eur J Cardiothorac Surg. 2010. PMID: 20137969 Clinical Trial.

6

Ex vivo characterization of γδ T-cell repertoire in patients after adoptive transfer of Vγ9Vδ2 T cells expressing the interleukin-2 receptor β-chain and the common γ-chain.

Izumi T, Kondo M, Takahashi T, Fujieda N, Kondo A, Tamura N, Murakawa T, Nakajima J, Matsushita H, Kakimi K. Izumi T, et al. Cytotherapy. 2013 Apr;15(4):481-91. doi: 10.1016/j.jcyt.2012.12.004. Epub 2013 Feb 5. Cytotherapy. 2013. PMID: 23391461 Clinical Trial.

7

Effect of IL-18 on expansion of gammadelta T cells stimulated by zoledronate and IL-2.

Li W, Kubo S, Okuda A, Yamamoto H, Ueda H, Tanaka T, Nakamura H, Yamanishi H, Terada N, Okamura H. Li W, et al. J Immunother. 2010 Apr;33(3):287-96. doi: 10.1097/CJI.0b013e3181c80ffa. J Immunother. 2010. PMID: 20445349

8

Aminobisphosphonate-pretreated dendritic cells trigger successful Vgamma9Vdelta2 T cell amplification for immunotherapy in advanced cancer patients.

Cabillic F, Toutirais O, Lavoué V, de La Pintière CT, Daniel P, Rioux-Leclerc N, Turlin B, Mönkkönen H, Mönkkönen J, Boudjema K, Catros V, Bouet-Toussaint F. Cabillic F, et al. Cancer Immunol Immunother. 2010 Nov;59(11):1611-9. doi: 10.1007/s00262-010-0887-0. Epub 2010 Jun 26. Cancer Immunol Immunother. 2010. PMID: 20582413

9

Clinical and immunological evaluation of zoledronate-activated Vgamma9gammadelta T-cell-based immunotherapy for patients with multiple myeloma.

Abe Y, Muto M, Nieda M, Nakagawa Y, Nicol A, Kaneko T, Goto S, Yokokawa K, Suzuki K. Abe Y, et al. Exp Hematol. 2009 Aug;37(8):956-68. doi: 10.1016/j.exphem.2009.04.008. Epub 2009 May 4. Exp Hematol. 2009. PMID: 19409955 Free article. Clinical Trial.

10

Essential requirements of zoledronate-induced cytokine and γδ T cell proliferative responses.

Nussbaumer O, Gruenbacher G, Gander H, Komuczki J, Rahm A, Thurnher M. Nussbaumer O, et al. J Immunol. 2013 Aug 1;191(3):1346-55. doi: 10.4049/jimmunol.1300603. Epub 2013 Jun 21. J Immunol. 2013. PMID: 23794630

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

163 results

Results by year